Forgot your password?
typodupeerror

Submission + - What Scientists Know About the Coronavirus Variant Spreading In the UK (nbcnews.com)

An anonymous reader writes: Several European countries have banned flights from the U.K. over fears about a new coronavirus variant that has forced millions of people in Britain to cancel their Christmas plans. Germany, the Netherlands, Belgium, Austria and Italy all announced restrictions on U.K. travel. Others will likely follow suit as scientists warned that the new strain spreads more quickly than its predecessor. [...] U.K. health officials first identified the new variant, which British scientists have called "VUI – 202012/01," in mid-September, Maria Van Kerkhove, the Covid-19 technical lead for the World Health Organization, told the BBC on Sunday.

Chris Whitty, the chief medical officer for England, warned in a statement Saturday that it the virus considered to be spreading more quickly. But he said there was no evidence so far to suggest that the new strain is more potent in terms of severe illness or death. "Our working assumption from all the scientists is that the vaccine response should be adequate for this virus," Patrick Vallance, the U.K. government's chief scientific adviser, said at a news briefing Saturday. But Ravindra Gupta, a professor of clinical microbiology at the University of Cambridge, said he was concerned that the virus is on a pathway to become resistant to vaccines. "Whilst it may not be actually resistant, it may not take so many changes after this for it to get there," he said. However, Clarke said that different versions of flu vaccines are required every year and that he did not see why it could not be the same for the coronavirus.

Biotech

FDA Approves Vaccine For Prostate Cancer 194

reverseengineer writes "The US Food and Drug Administration has given its first first approval for a therapeutic cancer vaccine. In a clinical trial 'involving 512 men, those who got Provenge (sipuleucel-T) had a median survival of 25.8 months after treatment, while those who got a placebo lived a median of 21.7 months. After three years, 32 percent of those who got Provenge were alive, compared with 23 percent of those who got the placebo. ... "The big story here is that this is the first proof of principle and proof that immunotherapy works in general in cancer, which I think is a huge observation," said Dr. Philip Kantoff, chief of solid tumor oncology at the Dana-Farber Cancer Institute in Boston and the lead investigator in Dendreon's largest clinical trial for the drug. "I think this is a very big thing and will lead to a lot more enthusiasm for the approach."'"
Science

Sweet, Sour, Salty, Bitter, Protein ... and Now Fat 210

ral writes "The human tongue can taste more than sweet, sour, salty, bitter and protein. Researchers have added fat to that list. Dr. Russell Keast, an exercise and nutrition sciences professor at Deakin University in Melbourne, told Slashfood, 'This makes logical sense. We have sweet to identify carbohydrate/sugars, and umami to identify protein/amino acids, so we could expect a taste to identify the other macronutrient: fat.' In the Deakin study, which appears in the latest issue of the British Journal of Nutrition, Dr. Keast and his team gave a group of 33 people fatty acids found in common foods, mixed in with nonfat milk to disguise the telltale fat texture. All 33 could detect the fatty acids to at least a small degree."

Comment Re:Other groups... (Score 1) 1197

ACM and IEEE no longer provide health insurance to new applicants. I had the IEEE plan and they forced people off by raising rates and lowering coverage(when I left it would only pay 20% of an ER bill. That's right, you got to pay 80%). Many chamber of commerce plans only work if you have at least 2 employees. At this time, COBRA plans in CA will not continue to coverage you after the expiration period even if you pay in advance whatever they ask for. Good luck.

Slashdot Top Deals

Keep the number of passes in a compiler to a minimum. -- D. Gries

Working...